Yidu Tech (HKSE:02158) Debt-to-Revenue : 0.02 (As of Sep. 2023)

View and export this data going back to 2021. Start your Free Trial

What is Yidu Tech Debt-to-Revenue?

Debt-to-Revenue measures a company's ability to pay off its debt.

Yidu Tech's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2023 was HK$10.7 Mil. Yidu Tech's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2023 was HK$6.1 Mil. Yidu Tech's annualized Revenue for the quarter that ended in Sep. 2023 was HK$764.8 Mil. Yidu Tech's annualized Debt-to-Revenue for the quarter that ended in Sep. 2023 was 0.02.

Yidu Tech Debt-to-Revenue Historical Data

The historical data trend for Yidu Tech's Debt-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Yidu Tech Debt-to-Revenue Chart

Yidu Tech Annual Data

Trend

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Debt-to-Revenue

Get a 7-Day Free Trial

3.82

0.94

0.03

0.04

0.02

Yidu Tech Semi-Annual Data
	Mar18	Mar19	Mar20	Sep20	Mar21	Sep21	Mar22	Sep22	Mar23	Sep23
Debt-to-Revenue	Get a 7-Day Free Trial					0.06	0.04	0.03	0.02	0.02

Competitive Comparison of Yidu Tech's Debt-to-Revenue

For the Health Information Services subindustry, Yidu Tech's Debt-to-Revenue, along with its competitors' market caps and Debt-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Yidu Tech's Debt-to-Revenue Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Yidu Tech's Debt-to-Revenue distribution charts can be found below:

* The bar in red indicates where Yidu Tech's Debt-to-Revenue falls into.

Yidu Tech Debt-to-Revenue Calculation

Debt-to-Revenue measures a company's ability to pay off its debt.

Yidu Tech's Debt-to-Revenue for the fiscal year that ended in Mar. 2023 is calculated as

Debt-to-Revenue	=	Total Debt			/	Revenue
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Revenue
	=	(10.864	+	5.228)	/	916.549
	=	0.02

Yidu Tech's annualized Debt-to-Revenue for the quarter that ended in Sep. 2023 is calculated as

Debt-to-Revenue	=	Total Debt			/	Revenue
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Revenue
	=	(10.696	+	6.085)	/	764.796
	=	0.02

In the calculation of annual Debt-to-Revenue, the Revenue of the last fiscal year is used. In calculating the annualized quarterly data, the Revenue data used here is two times the quarterly (Sep. 2023) Revenue data.

Yidu Tech Debt-to-Revenue Related Terms

Thank you for viewing the detailed overview of Yidu Tech's Debt-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Yidu Tech (HKSE:02158) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Yidu Tech Inc (HKSE:02158) » Definitions » Debt-to-Revenue

Comparable Companies

Traded in Other Exchanges

0EL:Germany

Address

No.9 Building of Huayuan North Road, 8th Floor Health Work, Haidian District, Beijing, CHN

Website

https://www.yidutechgroup.com

Yidu Tech offers healthcare Big Data. It is an AI cloud-based firm providing solutions and tools to aid in more informed decisions to drive better efficiency in clients' strategies. Its clients are hospitals, pharmaceutical, biotech and medical device firms, research institutions, insurance companies, patients, and regulators. It three business segments are: Big Data platform and solutions, which partners with hospitals and policymakers to drive better efficiency; life sciences solutions, which enables better probability of clinical trial success with less drug development time and cost; and health management solutions, which helps with patient management. The Big Data platform accounted for 33% of revenue, life science solutions 30%, and health management solutions 27%, in fiscal 2022.

Executives

Gong Yingying	2202 Interest of your spouse
Xu Jiming	2101 Beneficial owner
Brunei Investment Agency	2101 Beneficial owner
Gic Private Limited	2102 Investment manager
Sweet Panda Limited	2101 Beneficial owner

Yidu Tech (HKSE:02158) Headlines

No Headlines